NIH has changed its policy regarding Recombinant DNA Advisory Committee’s (RAC) review of individual human gene transfer trials.

Effective April 27, 2016, UCI’s Institutional Biosafety Committee will determine whether investigator-initiated research requires RAC review based on specific criteria.  The RAC Revision Factsheet includes a list of the criteria and a summary of the changes.  Also see the IBC and IRB related web pages for more information.